GSK plc vs Merck & Company, Inc. — Stock Comparison
GSK plc (GSK) and Merck & Company, Inc. (MRK) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Merck & Company, Inc. narrowly edges GSK plc on Q·Score (7 vs 6.3 out of 10), led by Sentiment (7.1 vs 3.3) and Health (7 vs 5.8). GSK plc scores higher on Quality, reflecting stronger profitability and returns. Analyst consensus targets imply greater upside for MRK (+13.9%) than for GSK (+11.8%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 41% return on equity and 18% profit margins.
⚠ cautious analyst consensus — few Buy ratings.
High-quality business with 19% return on equity and 14% profit margins.
Analyst Consensus
Fundamentals
Frequently Asked Questions
GSK vs MRK: which stock scores better overall?
Based on Q·Score, Merck & Company, Inc. (MRK) scores 7/10 versus GSK plc (GSK) at 6.3/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: GSK or MRK?
Merck & Company, Inc. (MRK) scores higher on Growth (6.2/10 vs 5.8/10). GSK plc reports revenue growth (1.5% YoY) while Merck & Company, Inc. reports (4.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is GSK or MRK more attractively valued?
GSK plc (GSK) scores higher on Valuation (7/10 vs 6.7/10). GSK trades at 9.7× P/E versus MRK at 11.9×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about GSK vs MRK?
There are 7 analysts covering GSK with a consensus price target of $56.63, and 27 analysts covering MRK with a consensus target of $129.74. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: GSK or MRK?
GSK plc (GSK) scores higher on Quality (8.5/10 vs 7.7/10). Net profit margin: GSK at 17.8%, MRK at 13.6%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: GSK or MRK?
Merck & Company, Inc. (MRK) scores higher on Financial Health (7/10 vs 5.8/10). Market beta: GSK at 0.29, MRK at 0.22. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of GSK and MRK?
GSK plc (GSK) has a market capitalisation of $101.5B, while Merck & Company, Inc. (MRK) has a market cap of $281.2B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do GSK or MRK pay dividends?
GSK does not currently pay a dividend, while MRK pays a dividend yield of 2.95%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →